Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of tumor tissue in the laboratory from patients with nonmelanoma
skin cancer that has been treated with topical aminolevulinic acid may help doctors predict
how patients will respond to photodynamic therapy.
PURPOSE: This clinical trial is studying topical aminolevulinic acid in patients with
nonmelanoma skin cancer.